Ideal Medical Technologies was founded by Dr. Leon DeJournett, who is board certified in Pediatrics and Pediatric Critical Care Medicine. Dr. DeJournett has combined his 30 years of Intensive Care Unit (ICU) experience with a thorough knowledge of the human body's native glucose control system to develop an artificial intelligence based artificial pancreas for use in the ICU setting.
We ask the tough questions and solve complex problems.
Is there a better way that will improve patient outcomes, lower healthcare expenditures, and use less resources?
If so, how can we get there?
How can we incorporate Artificial Intelligence into this process?
Artificial Intelligence in Medicine: Patient-Centered Innovation for:
Our Latest News
2014 – Ideal Medical Technologies Incorporated in Deleware.
February 2015 – Ideal Medical Technologies issued U.S. Patent rights.
August 2015 – Ideal Medical Technologies closes seed round of funding.
Later 2016 – Ideal Medical Technologies plans to complete first in-human testing
of working prototype.